The reported regulatory function of HTATIP2 on cytoplasmic–nuclear transport of proteins incited us to investigate the repair enzyme MPG as a treatment relevant candidate, based on our previous observation of predominantly nuclear or cytoplasmic localization of MPG in a subset of GBM [18] (Fig. 1). The gene discussed is MPG; the disease is glioblastoma.